Oncology

Filter

Expert Insights on HER2-Mutant NSCLC

6 Mins

October 2025

Dr. Joshua Sabari explores recent advances in the treatment of HER2-mutant non-small cell lung cancer, including a newly FDA-approved option…

Current Approaches to Recurrent and Metastatic Cervical Cancer

Despite improved screening and treatment in developing nations, cervical cancer continues to have a global incidence of approximately…

High-Grade Gallbladder Neuroendocrine Tumor in a Young Female

Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms that originate from cells of the diffuse neuroendocrine system…

Prolonged Survival in Fibrolamellar HCC Treatment

Liver cancer is a leading global health concern, ranking as the sixth most common cancer and the third deadliest in 2022, with over…

Adjuvant Nivolumab in MIBC: Lessons from CheckMate 274

New analysis reveals nivolumab’s impact on disease-free survival in high-risk muscle-invasive bladder cancer.

Precision Approaches in Colorectal Cancer: Interview with John Strickler

It has been known for years that there is a small subgroup of patients with colorectal cancer who have HER2-positive disease…

Pioneering Precision Medicine in Prostate Cancer

Prostate cancer is the second most common cancer and the fifth leading cause of cancer death in males worldwide, with over 1.4 million…

Wearable Devices for Vital Sign Monitoring in Haematology and Oncology

Traditional vital sign monitoring in acute hospital settings relies on sporadic checks, posing significant challenges for hematological…

Laterality Bias in Mammogram Screening

Quality is important in breast imaging, and there exist a number of excellent screening mammography quality metrics to audit readers…

Loading posts...

« Previous 1 2 3 Next »